HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walgreen

This article was originally published in The Rose Sheet

Executive Summary

Price reductions on thousands of cosmetics and promotional categories implemented to bring more customers into stores, company says in report of fiscal fourth quarter and year end (ended Aug. 31) results. Lower prices intended to allow drug chain to better compete with mass merchandisers, firm states. Walgreen reduced prices on cosmetics between 5%-20%. Net sales for fourth quarter jumped 16.8% to $6.28 bil., and net earnings were flat at $216.9 mil. Net sales for the year were up 16.1% to $24.62 bil., while earnings were up 14% to $885.6 mil., firm says

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel